ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Social Stream
PROQR THERAPEUTICS NV (PRQR) Price Targets From Analysts
Use the tables below to see what analysts covering PROQR THERAPEUTICS NV think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-28 | 6 | $33 | $18 | $22.75 | $2.01 | 1031.84% |
| 2022-01-31 | 5 | $33 | $18 | $22 | $2.01 | 994.53% |
| 2022-02-14 | 6 | $18 | $1.7 | $6.74 | $2.01 | 235.32% |
| 2022-02-28 | 6 | $8 | $1.7 | $4.74 | $2.01 | 135.82% |
| 2022-04-17 | 5 | $4 | $1.7 | $2.8 | $2.01 | 39.3% |
| 2022-04-19 | 5 | $4 | $1.7 | $2.94 | $2.01 | 46.27% |
| 2022-05-09 | 6 | $2.5 | $1 | $1.8 | $2.01 | -10.45% |
| 2022-08-06 | 6 | $3.5 | $1 | $2.04 | $2.01 | 1.49% |
| 2022-08-15 | 7 | $3.5 | $1 | $1.95 | $2.01 | -2.99% |
| 2022-11-10 | 7 | $2 | $0.8 | $1.4 | $2.01 | -30.35% |
| 2022-12-23 | 6 | $5 | $1 | $2.84 | $2.01 | 41.29% |
| 2023-05-17 | 6 | $6 | $2 | $4.6 | $2.01 | 128.86% |
| 2023-08-07 | 6 | $6 | $2 | $4.5 | $2.01 | 123.88% |
| 2023-09-18 | 6 | $6 | $1.8 | $4.05 | $2.01 | 101.49% |
| 2023-11-08 | 6 | $6 | $1.8 | $3.76 | $2.01 | 87.06% |
| 2023-11-10 | 7 | $6 | $1.8 | $3.76 | $2.01 | 87.06% |
The Trend in the Analyst Price Target
Over the past 27 months, PRQR's average price target has gone down $21.75.
PRQR reports an average of 181.22% for its upside potential over the past 32 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-30 | 6 | 6 | 2.0 | 4.600 | 1.99 | 131.16% |
| 2023-09-18 | 6 | 6 | 1.8 | 4.050 | 1.54 | 162.99% |
| 2023-11-08 | 7 | 6 | 1.8 | 4.200 | 1.35 | 211.11% |
| 2023-11-08 | 7 | 6 | 1.8 | 3.883 | 1.35 | 187.63% |
| 2023-11-08 | 6 | 6 | 1.8 | 3.760 | 1.35 | 178.52% |
PRQR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.43 | 5 | 1 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 26 weeks, PRQR's average broker recommendation rating improved by 0.4.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRQR as an investment opportunity.
- In the context of all US stocks, PROQR THERAPEUTICS NV's average analyst price target is greater than 141.33% of them.
- In terms of how PROQR THERAPEUTICS NV fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2362.61% of that group.
- In terms of how PROQR THERAPEUTICS NV fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 1950.76% of that group.
- In terms of how PROQR THERAPEUTICS NV fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 1359.45% of that group.
Stocks similar to PROQR THERAPEUTICS NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AFMD, SMMT, and KALV.
View All Top Stocks by Price Target
Is PRQR a Buy, Hold or Sell? See the POWR Ratings now!